Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P F Lebowitz

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Oncogene|October 21, 1998
Non-Ras targets of farnesyltransferase inhibitors: focus on RhoP F Lebowitz, G C Prendergast
Cell Adhesion and Communication|December 29, 1998
Functional interaction between RhoB and the transcription factor DB1P F Lebowitz, G C Prendergast
Molecular and Cellular Biology|February 18, 1999
Cell growth inhibition by farnesyltransferase inhibitors is mediated by gain of geranylgeranylated RhoBW Du, P F Lebowitz, G C Prendergast
Cancer Research|February 15, 1997
Farnesyl transferase inhibitors induce apoptosis of Ras-transformed cells denied substratum attachmentP F Lebowitz, D Sakamuro, G C Prendergast
Cancer Research|May 8, 1999
Elevation of alpha2(I) collagen, a suppressor of Ras transformation, is required for stable phenotypic reversion by farnesyltransferase inhibitorsW Du, P F Lebowitz, G C Prendergast
The Journal of Biological Chemistry|June 27, 1997
Prenylation of RhoB is required for its cell transforming function but not its ability to activate serum response element-dependent transcriptionP F Lebowitz, W Du, G C Prendergast
Molecular and Cellular Biology|December 1, 1995
Evidence that farnesyltransferase inhibitors suppress Ras transformation by interfering with Rho activityP F Lebowitz, J P Davide, G C Prendergast
The Journal of Biological Chemistry|June 20, 1997
Farnesyltransferase inhibitors alter the prenylation and growth-stimulating function of RhoBP F Lebowitz, P J Casey, G C Prendergast, et al.
Cancer Research|June 1, 1996
Resistance of a variant ras-transformed cell line to phenotypic reversion by farnesyl transferase inhibitorsG C Prendergast, J P Davide, P F Lebowitz, et al.
Oncogene|June 15, 1995
Critical role of Rho in cell transformation by oncogenic RasG C Prendergast, R Khosravi-Far, P A Solski, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Oncogene|October 21, 1998
Non-Ras targets of farnesyltransferase inhibitors: focus on RhoP F Lebowitz, G C Prendergast
Cell Adhesion and Communication|December 29, 1998
Functional interaction between RhoB and the transcription factor DB1P F Lebowitz, G C Prendergast
Molecular and Cellular Biology|February 18, 1999
Cell growth inhibition by farnesyltransferase inhibitors is mediated by gain of geranylgeranylated RhoBW Du, P F Lebowitz, G C Prendergast
Cancer Research|February 15, 1997
Farnesyl transferase inhibitors induce apoptosis of Ras-transformed cells denied substratum attachmentP F Lebowitz, D Sakamuro, G C Prendergast
Cancer Research|May 8, 1999
Elevation of alpha2(I) collagen, a suppressor of Ras transformation, is required for stable phenotypic reversion by farnesyltransferase inhibitorsW Du, P F Lebowitz, G C Prendergast
The Journal of Biological Chemistry|June 27, 1997
Prenylation of RhoB is required for its cell transforming function but not its ability to activate serum response element-dependent transcriptionP F Lebowitz, W Du, G C Prendergast
Molecular and Cellular Biology|December 1, 1995
Evidence that farnesyltransferase inhibitors suppress Ras transformation by interfering with Rho activityP F Lebowitz, J P Davide, G C Prendergast
The Journal of Biological Chemistry|June 20, 1997
Farnesyltransferase inhibitors alter the prenylation and growth-stimulating function of RhoBP F Lebowitz, P J Casey, G C Prendergast, et al.
Cancer Research|June 1, 1996
Resistance of a variant ras-transformed cell line to phenotypic reversion by farnesyl transferase inhibitorsG C Prendergast, J P Davide, P F Lebowitz, et al.
Oncogene|June 15, 1995
Critical role of Rho in cell transformation by oncogenic RasG C Prendergast, R Khosravi-Far, P A Solski, et al.
Pageof 1